At a landmark meeting in La Jolla, Calif., in February 2014, 35 leading global scientists from the public and private sectors came together to discuss the creation of the Human Vaccines Project
, and the primary scientific hurdles impeding the development of new vaccines . Recognizing the potential of recent technological advances in genomics, bioinformatics and systems biology, participants unanimously endorsed their vision and mission as potentially transformative for human health, and called for a decade-long, $1 billion-plus effort to decode the human immune system.
Initially incubated by the International AIDS Vaccines Initiative (IAVI) with seed funding from the Robert Wood Johnson Foundation, the Human Vaccines Project followed this first meeting with a series of workshops on specific components of its scientific and business plans. With a growing number of collaborations, the Human Vaccines Project was spun out as an independent global nonprofit organization, supported by a founding Board of Directors and an internationally recognized Scientific Steering Committee
The Human Vaccines Project is a global nonprofit that brings together leading stakeholders across academia, industry, governments and nonprofits.
Focused on the pre-competitive immunology research space, their mission is to accelerate the development of vaccines and immunotherapies against major global infectious diseases and cancers by decoding the human immune system.
Under their consortium model, they have created a network of leading university and academic research centers that serve as their scientific hubs. These scientific hubs work collaboratively to develop and execute their scientific plan. They are bound together by innovative legal agreements, which provide for the sharing of data and materials, the rapid public release of data and shared IP with Global Access provisions to ensure benefits of the Project’s scientific breakthroughs reach populations globally.